99 related articles for article (PubMed ID: 12023017)
1. Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178).
Ghadimi MP; Sanzenbacher R; Thiede B; Wenzel J; Jing Q; Plomann M; Borkhardt A; Kabelitz D; Janssen O
FEBS Lett; 2002 May; 519(1-3):50-8. PubMed ID: 12023017
[TBL] [Abstract][Full Text] [Related]
2. Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor.
Wenzel J; Sanzenbacher R; Ghadimi M; Lewitzky M; Zhou Q; Kaplan DR; Kabelitz D; Feller SM; Janssen O
FEBS Lett; 2001 Dec; 509(2):255-62. PubMed ID: 11741599
[TBL] [Abstract][Full Text] [Related]
3. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
[TBL] [Abstract][Full Text] [Related]
4. Caspase-dependent cleavage of the hematopoietic specific adaptor protein Gads alters signalling from the T cell receptor.
Berry DM; Benn SJ; Cheng AM; McGlade CJ
Oncogene; 2001 Mar; 20(10):1203-11. PubMed ID: 11313864
[TBL] [Abstract][Full Text] [Related]
5. Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytes.
Linkermann A; Gelhaus C; Lettau M; Qian J; Kabelitz D; Janssen O
Biochim Biophys Acta; 2009 Feb; 1794(2):168-76. PubMed ID: 19041431
[TBL] [Abstract][Full Text] [Related]
6. Slowly getting a clue on CD95 ligand biology.
Linkermann A; Qian J; Janssen O
Biochem Pharmacol; 2003 Oct; 66(8):1417-26. PubMed ID: 14555216
[TBL] [Abstract][Full Text] [Related]
7. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter.
Kirchhoff S; Sebens T; Baumann S; Krueger A; Zawatzky R; Li-Weber M; Meinl E; Neipel F; Fleckenstein B; Krammer PH
J Immunol; 2002 Feb; 168(3):1226-34. PubMed ID: 11801659
[TBL] [Abstract][Full Text] [Related]
8. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
9. Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT.
Asada H; Ishii N; Sasaki Y; Endo K; Kasai H; Tanaka N; Takeshita T; Tsuchiya S; Konno T; Sugamura K
J Exp Med; 1999 May; 189(9):1383-90. PubMed ID: 10224278
[TBL] [Abstract][Full Text] [Related]
10. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
[TBL] [Abstract][Full Text] [Related]
11. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
den Hertog J; Hunter T
EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
[TBL] [Abstract][Full Text] [Related]
12. CD95 ligand expression as a mechanism of immune escape in breast cancer.
Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
[TBL] [Abstract][Full Text] [Related]
13. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.
Li-Weber M; Krammer PH
Semin Immunol; 2003 Jun; 15(3):145-57. PubMed ID: 14563113
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
Aragane Y; Kulms D; Metze D; Wilkes G; Pöppelmann B; Luger TA; Schwarz T
J Cell Biol; 1998 Jan; 140(1):171-82. PubMed ID: 9425165
[TBL] [Abstract][Full Text] [Related]
15. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice.
Norian LA; Latinis KM; Eliason SL; Lyson K; Yang C; Ratliff T; Koretzky GA
J Immunol; 2000 May; 164(9):4471-80. PubMed ID: 10779747
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation.
Melino G; Bernassola F; Catani MV; Rossi A; Corazzari M; Sabatini S; Vilbois F; Green DR
Cancer Res; 2000 May; 60(9):2377-83. PubMed ID: 10811113
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
[TBL] [Abstract][Full Text] [Related]
18. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
Li-Weber M; Laur O; Dern K; Krammer PH
Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
[TBL] [Abstract][Full Text] [Related]
19. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
20. Requirement for Shc in TCR-mediated activation of a T cell hybridoma.
Pratt JC; van den Brink MR; Igras VE; Walk SF; Ravichandran KS; Burakoff SJ
J Immunol; 1999 Sep; 163(5):2586-91. PubMed ID: 10452997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
